ORABLOC

Brand name authorized in: Austria Canada France Poland United States

Active ingredients

The drug ORABLOC contains a combination of these active pharmaceutical ingredients (APIs):

1 Articaine
UNII QS9014Q792 - ARTICAINE HYDROCHLORIDE

Articaine is a local anaesthetic of the amide type. Preclinical pharmacodynamic studies show that the mechanism of action of articaine is similar to that of other commonly used anaesthetics.

Read about Articaine
2 Epinephrine
UNII 30Q7KI53AK - EPINEPHRINE BITARTRATE

Epinephrine is a direct acting sympathomimetic agent, which exerts effects on both α and β adrenoceptors. It has more pronounced effects on β than on α adrenoceptors, although α effects prevail at high doses. The effects of adrenaline include increased rate and force of cardiac contraction, cutaneous vasoconstriction and broncho-dilatation.

Read about Epinephrine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Articaine, combinations
N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB58

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
CA
Health Products and Food Branch
Identifier(s): 02361906, 02361914
FR
Base de données publique des médicaments
Identifier(s): 66284448, 67227749
PL
Rejestru Produktów Leczniczych
Identifier(s): 100308210, 100308226
US
FDA, National Drug Code
Identifier(s): 45146-110, 45146-120